Manufacturing Consensus, Marketing Truth: Guidelines for Economic Evaluation
Authors: Robert G. Evans
Journal: Annals of Internal Medicine (1995)

Editorials1 July 1995Manufacturing Consensus, Marketing Truth: Guidelines for Economic EvaluationRobert G. Evans, PhDRobert G. Evans, PhDUniversity of British Columbia, Vancouver, BC V6T 123, Canada.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-123-1-199507010-00010 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Economic analysis is increasingly applied to medical practices. Interest in both the methods and the results of these analyses is growing on all sides. This issue of Annals contains a report from a task force, organized by faculty from the Leonard Davis Institute of the University of Pennsylvania, with financial support from industry sources, that examines the issue of standard setting for economic analyses of health care technologies. A contrasting view appears in the following editorial. Readers interested in an international perspective on the topic will want to read the recent editorial by Freemantle and colleagues (BMJ. 1995; 310:955-6).—The Editor... References1. Culyer AJ, Wiseman J, Walker A. An Annotated Bibliography of Health Economics: English Language Sources. New York: St Martin's; 1977. Google Scholar2. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford Univ Pr; 1987. Google Scholar3. Dorfman R, ed. Measuring Benefits of Government Investments. Washington, DC: Brookings Inst; 1965. Google Scholar4. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology. A report on principles. Ann Intern Med. 1995; 123:61-70. Google Scholar5. Marwick C. Pharmacoeconomics: is a drug worth its cost? JAMA. 1994; 272:1395. Google Scholar6. Weber J, Bhargava SW. Drugmakers Get a Taste of Their Own Medicine. Business Week. 1993 Apr 26: 104-5. Google Scholar7. Levit KR, Cowan CA, Lazenby HC, McDonnell PA, Sensenig AL, Stiller JM, et al. National health spending trends, 1960-1993. Health Aff (Millwood). 1994; 13:14-31. Google Scholar8. Pharmaceutical Research and Manufacturers of America. Methodological and Conduct Principles for Pharmacoeconomic Research. Washington, D.C.: PhRMA; January, 1995. Google Scholar Author, Article, and Disclosure InformationAffiliations: University of British Columbia, Vancouver, BC V6T 123, Canada.Corresponding Author: Robert G. Evans, PhD, Centre for Health Services and Policy Research, Room 429, 2194 Health Sciences Mall, Vancouver, BC V6T 123, Canada. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe impact of research and development and marketing costs on the profitability of pharmaceutical companies of Tehran Stock Exchange using panel data 2001-2013Dollars and SenseWhen Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of StatinsMuted Incentives, Omitted Variables, and Pharmacoeconomic Validity: Two Strikes and You're Out!Adapting pharmacoeconomic data and methods to extend the postpublication utility of analysesTrends in Cost Effectiveness Analyses in Orthopaedic SurgeryChoice of modelling technique for evaluating health care interventionsBenefit assessment of therapeutic products: the Centers for Education and Research on TherapeuticsPharmacoeconomics: a Reliable Tool for Decisions on New Medicines?Medicare and Cost-Effectiveness AnalysisApplication of Economic Analysis to Diabetes and Diabetes CarePing Zhang, PhD, Michael M. Engelgau, MD, Susan L. Norris, MD, Edward W. Gregg, PhD, and K. M. Venkat Narayan, MDIntegrating ethical enquiry and health technology assessment: limits and opportunities for efficiency and equityPharmacoeconomic studies and the pharmaceutical industry: bias in which direction?Standards and certification to recognize pharmacoeconomics as a professionOntario??s Formulary CommitteeEconomic Analysis and Clinical ResearchPharmacoeconomics in anaesthesia: what are the issues?Pharmacoeconomics in anaesthesiaConflict of interest in industrysponsored economic evaluations: Real or imagined?Cost Analysis of Vaginal Birth After CesareanDesign Issues for Conducting Cost-Effectiveness Analyses Alongside Clinical TrialsBiogeochemical Processes Regulating Metal BehaviorModel-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and PositioningHealth economists meet the fourth tempter: drug dependency and scientific discourseSTANDARDS FOR ECONOMIC AND QUALITY OF LIFE STUDIES IN TRANSPLANTATIONThe Quality of Reporting in Published Cost-Utility Analyses, 1976–1997Peter J. Neumann, ScD, Patricia W. Stone, PhD, MPH, RN, Richard H. Chapman, SM, Eileen A. Sandberg, SM, MBA, and Chaim M. Bell, MDSaving Lives, Saving Money: Shepherding the Role of TechnologyLa declaración del conflicto de intereses en las publicaciones científicas. ¿Tiempo para las luces y los taquígrafos en la trastienda de la investigación financiada por la industria?Terminology I would like to see disappearRaising the quality of cost-utility analyses: lessons learnt and still to learnIs health economics useful in cancer?Resources Used by PanelistsPaying the Piper for Pharmacoeconomic StudiesRevenue Streams and Clinical DiscretionA summary of economic evaluations published in the field of rheumatology and related disciplinesAfter compulsory licensing: coming issues in Canadian pharmaceutical policy and politicsEvidence-based medicine and treatment choicesA Comparison of Costs and Efficacy of Ondansetron and Droperidol as Prophylactic Antiemetic Therapy for Elective Outpatient Gynecologic ProceduresWhat place for R&D in tomorrow's drug industry?Paper two: Allocation of scarce resources: The need for critical analysisEmergenceApplications to Social Systems (1) 1 July 1995Volume 123, Issue 1Page: 59-60KeywordsDrug informationDrug marketingDrug regulationDrugsHealth careHealth economicsMortalityMotivationPharmacoeconomicsResearch reporting guidelines Issue Published: 1 July 1995 Copyright & PermissionsCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...